| |
| |
|
| Insider
Information: |
Cantor Maria E |
| Relationship: |
SVP, Investor Rel. & C... |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
228,106 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$405,807 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
228,106 |
|
|
| Total
Value |
$405,807 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Ariad Pharmaceuticals Inc |
ARIA |
SVP, Corporate Affairs |
2016-03-19 |
135,667 |
|
0 |
Premium* |
|
|
uniQure B.V. |
QURE |
SVP, Investor Rel. & C... |
2018-01-26 |
92,439 |
2017-12-13 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| QURE |
uniQure B.V. |
SVP, Investor Rel. & Comm. |
• – – |
2018-01-26 |
4 |
A |
$0.00 |
$0 |
D/D |
7,188 |
92,439 |
0 |
- |
|
| QURE |
uniQure B.V. |
SVP, Investor Relations & Comm |
• – – |
2018-01-03 |
4 |
S |
$20.13 |
$118,028 |
D/D |
(5,864) |
85,251 |
0 |
- |
|
| QURE |
uniQure B.V. |
SVP, Investor RelationsSVP, In |
• – – |
2017-12-13 |
4 |
A |
$0.00 |
$0 |
D/D |
56,115 |
56,115 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, Corporate Affairs |
• – – |
2016-03-19 |
4 |
AS |
$6.46 |
$23,102 |
D/D |
(3,575) |
135,667 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, Corporate Affairs |
• – – |
2016-03-19 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,500 |
139,242 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, Corporate Affairs |
• • – |
2016-03-03 |
4 |
AS |
$6.12 |
$58,869 |
D/D |
(9,625) |
132,742 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, Corporate Affairs |
• • – |
2016-03-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
19,250 |
142,367 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, Corporate Affairs |
• • – |
2016-02-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
29,333 |
139,250 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, Corporate Affairs |
• • – |
2016-02-01 |
4 |
AS |
$4.81 |
$77,745 |
D/D |
(16,133) |
123,117 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, Corporate Affairs |
• • – |
2015-09-28 |
4 |
AS |
$6.47 |
$32,327 |
D/D |
(5,000) |
109,917 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, Corporate Affairs |
• • – |
2015-09-24 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,000 |
114,917 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, Corporate Affairs |
• • – |
2015-09-01 |
4 |
AS |
$9.11 |
$24,557 |
D/D |
(2,696) |
104,917 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, Corporate Affairs |
• • – |
2015-08-28 |
4 |
AS |
$10.00 |
$12,680 |
D/D |
(1,268) |
107,613 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, Corporate Affairs |
• • – |
2015-07-16 |
4 |
AS |
$8.54 |
$34,162 |
D/D |
(4,000) |
108,881 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, Corporate Affairs |
• • – |
2015-07-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,000 |
112,881 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, Corporate Affairs and HR |
• • – |
2015-03-23 |
4 |
AS |
$8.55 |
$34,491 |
D/D |
(4,033) |
104,881 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, Corporate Affairs and HR |
• • – |
2015-03-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,333 |
108,916 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, Corporate Affairs and HR |
• • – |
2015-03-20 |
4 |
AS |
$8.85 |
$31,627 |
D/D |
(3,575) |
101,583 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, Corporate Affairs and HR |
• • – |
2015-03-19 |
4 |
AS |
$9.00 |
$84,114 |
D/D |
(9,346) |
105,158 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, Corporate Affairs and HR |
• • – |
2015-03-19 |
4 |
OE |
$0.00 |
$24,255 |
D/D |
14,375 |
114,504 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, Corporate Affairs and HR |
• • – |
2015-02-02 |
4 |
AS |
$6.33 |
$102,089 |
D/D |
(16,134) |
100,129 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, Corporate Affairs and HR |
• • – |
2015-02-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
29,334 |
116,263 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, Corporate Affairs and HR |
• • – |
2014-11-24 |
4 |
AS |
$7.00 |
$12,243 |
D/D |
(1,749) |
86,929 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, Corporate Affairs and HR |
• • – |
2014-09-02 |
4 |
AS |
$6.21 |
$16,753 |
D/D |
(2,696) |
88,678 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, Corporate Affairs and HR |
• • – |
2014-07-15 |
4 |
D |
$5.57 |
$14,527 |
D/D |
(2,608) |
91,374 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
